Several functional assays showed that VPS9D1-AS1 knockdown by its siRNA attenuated NSCLC cell proliferation, migration, and invasiveness in vitro; moreover, it promoted apoptosis and attenuated tumor growth in vivo. This evidence concerns the gene VPS9D1 and non-small cell lung carcinoma.